Department of Medicine, Kamuzu University of Health Sciences, Blantyre, Malawi.
Department of Rehabilitation Sciences, School of Life Sciences and Allied Health Professions, Kamuzu University of Health Sciences, Blantyre, Malawi.
Malawi Med J. 2023 Dec;35(4):201-207. doi: 10.4314/mmj.v35i4.1.
Extra-pulmonary tuberculosis (EPTB) accounts for 15% of the 1.4 million patients with TB notified in 2019. EPTB carries a high risk of mortality and so early diagnosis and treatment are important to reduce this risk. Diagnosis of EPTB in low- and middle-income countries is challenging. This study investigated the diagnostic performance of Xpert MTB Ultra for the diagnosis of EPTB (pericardial, pleural, and ascitic fluid) in adults at a referral hospital in Malawi.
Adults with suspected extra-pulmonary TB were screened for evidence of extra-pulmonary fluid and tested for TB using Xpert MTB Ultra, mycobacterial culture, and a Focused Abdominal Sonography in HIV-associated TB (FASH scan). The diagnostic performance of the Xpert MTB Ultra was compared to mycobacterial culture and a composite reference standard defined as a positive FASH scan or a positive mycobacterial culture or a clinical TB diagnosis (constitutional symptoms not otherwise explained with response to empirical TB treatment).
There were 174 patients recruited: 99/174 (57%) pleural, 70/174 (40%) ascitic and 5/174 (3%) pericardial. Overall, 10/174 (6%) had bacteriologically confirmed TB and 30/174 (17%) were started on TB treatment based on a positive FASH scan or a clinical TB diagnosis. The sensitivity and specificity of Xpert ultra compared to culture was 83% (95%CI:36%-100%) and 98% (95%CI:94%-99%), respectively. Compared to the composite reference standard, the sensitivity of Xpert Ultra was 17% (95%CI:7%-34%) and specificity was 98% (95%CI:94%-100%).
Xpert MTB Ultra provides good diagnostic performance on pleural, pericardial and ascitic fluid with reference to mycobacterial culture. Improved EPTB diagnostic tests are required to improve patient outcomes. We recommend larger multi-centre studies to corroborate our findings.
2019 年,在报告的 140 万例结核病患者中,肺外结核(EPTB)占 15%。EPTB 死亡率较高,因此早期诊断和治疗对于降低这种风险很重要。在中低收入国家诊断 EPTB 具有挑战性。本研究调查了 Xpert MTB Ultra 在马拉维一家转诊医院对成人心包、胸腔和腹腔积液的 EPTB 诊断的诊断性能。
对疑似肺外结核的成年人进行筛查,以寻找肺外液的证据,并使用 Xpert MTB Ultra、分枝杆菌培养和 HIV 相关结核的焦点腹部超声(FASH 扫描)进行结核检测。将 Xpert MTB Ultra 的诊断性能与分枝杆菌培养和综合参考标准进行比较,综合参考标准定义为 FASH 扫描阳性、分枝杆菌培养阳性或临床结核病诊断(无其他原因的全身症状,对经验性结核病治疗有反应)。
共纳入 174 例患者:99/174(57%)为胸腔积液,70/174(40%)为腹腔积液,5/174(3%)为心包积液。总体而言,10/174(6%)有细菌学证实的结核病,30/174(17%)根据 FASH 扫描阳性或临床结核病诊断开始接受结核病治疗。与培养相比,Xpert Ultra 的敏感性和特异性分别为 83%(95%CI:36%-100%)和 98%(95%CI:94%-99%)。与综合参考标准相比,Xpert Ultra 的敏感性为 17%(95%CI:7%-34%),特异性为 98%(95%CI:94%-100%)。
与分枝杆菌培养相比,Xpert MTB Ultra 在心包、胸腔和腹腔积液中具有良好的诊断性能。需要改进 EPTB 诊断检测方法以改善患者结局。我们建议进行更大规模的多中心研究来证实我们的发现。